VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma
Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma. The Lancet Oncology.
authors with profiles
L JEFFREY MEDEIROS